Hidradenitis Suppurativa Clinical Trials
Hidradenitis Suppurativa clinical trials study new biologics, small-molecule drugs, and treatment approaches for hidradenitis Suppurativa and related immune or inflammatory conditions. Corterve gathers actively recruiting Hidradenitis Suppurativa studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Hidradenitis Suppurativa studies
- An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HSNCT07665437PHASE3Novartis PharmaceuticalsHidradenitis SuppurativaFort Smith, Arkansas
- ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis SuppurativaNCT07783542PHASE2Oruka Therapeutics, Inc.Hidradenitis Suppurativa (HS)Birmingham, Alabama
- Safety and Efficacy of Soquelitinib in Adults With Hidradenitis SuppurativaNCT07828860PHASE1Corvus Pharmaceuticals, Inc.Hidradenitis Suppurativa (HS)West Lafayette, Indiana
- A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNCT07225569PHASE2SanofiHidradenitis SuppurativaScottsdale, Arizona
- Regulation of Inflammatory Genes in Hidradenitis SuppurativaNCT05507125University of Alabama at BirminghamHidradenitis SuppurativaBirmingham, Alabama
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)NCT06888193PHASE1UCB Biopharma SRLModerate to Severe Plaque PsoriasisSanta Monica, California
- Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis SuppurativaNCT07049575PHASE1Incyte CorporationHidradenitis SuppurativaPhoenix, Arizona
- Rollover Study for Participants Previously Enrolled in Clinical Trials of PovorcitinibNCT06855498PHASE3Incyte CorporationHidradenitis Suppurativa (HS)Birmingham, Alabama
- Targeting Nociceptors in Hidradenitis SuppurativaNCT05403710University of Massachusetts, WorcesterHidradenitis SuppurativaWorcester, Massachusetts
- Capsule Microbiota Transplant Therapy for Hidradenitis SuppurativaNCT06058520EARLY_PHASE1University of MinnesotaHidradenitis SuppurativaMinneapolis, Minnesota
- Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.NCT06326476EARLY_PHASE1University of Alabama at BirminghamHidradenitis SuppurativaBirmingham, Alabama
- Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaNCT07170917PHASE2SanofiHidradenitis SuppurativaPhoenix, Arizona
Hidradenitis Suppurativa trials by state
Hidradenitis Suppurativa trials by metro
Frequently asked questions
- How do I find recruiting Hidradenitis Suppurativa clinical trials?
- Browse the actively recruiting Hidradenitis Suppurativa studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Hidradenitis Suppurativa clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Hidradenitis Suppurativa clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.